HEADER ANTIVIRAL PROTEIN 03-AUG-22 8DXT TITLE FAB ARM OF ANTIBODY GAR12 BOUND TO THE RECEPTOR BINDING DOMAIN OF TITLE 2 SARS-COV-2. COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIGHT CHAIN OF FAB ARM OF ANTIBODY GAR12; COMPND 3 CHAIN: L; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: LIGHT CHAIN OF FAB ARM OF ANTIBODY GAR12; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HEAVY CHAIN OF FAB ARM OF ANTIBODY GAR12; COMPND 8 CHAIN: H; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: HEAVY CHAIN OF FAB ARM OF ANTIBODY GAR12, WITH A 6HIS COMPND 11 TAG AT THE C-TERMINUS; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: SPIKE PROTEIN S1; COMPND 14 CHAIN: R; COMPND 15 FRAGMENT: RECEPTOR BINDING DOMAIN; COMPND 16 ENGINEERED: YES; COMPND 17 OTHER_DETAILS: SARS COV-2 RECEPTOR BINDING DOMAIN RESIDUES 333-528 COMPND 18 WITH A 6HIS TAG AT THE C-TERMINUS SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: EXPICHO; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 14 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: EXPICHO; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 19 2; SOURCE 20 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 21 ORGANISM_TAXID: 2697049; SOURCE 22 GENE: S, 2; SOURCE 23 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 24 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 26 EXPRESSION_SYSTEM_CELL_LINE: EXPICHO KEYWDS ANTI-COV-2, ANTIBODIES, CONVALESCENT PATIENTS, RECEPTOR BINDING KEYWDS 2 DOMAIN., ANTIVIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.B.LANGLEY,D.CHRIST,J.Y.HENRY REVDAT 3 25-OCT-23 8DXT 1 REMARK REVDAT 2 22-FEB-23 8DXT 1 JRNL REVDAT 1 18-JAN-23 8DXT 0 JRNL AUTH R.ROUET,J.Y.HENRY,M.D.JOHANSEN,M.SOBTI,H.BALACHANDRAN, JRNL AUTH 2 D.B.LANGLEY,G.J.WALKER,H.LENTHALL,J.JACKSON,S.UBIPARIPOVIC, JRNL AUTH 3 O.MAZIGI,P.SCHOFIELD,D.L.BURNETT,S.H.J.BROWN,M.MARTINELLO, JRNL AUTH 4 B.HUDSON,N.GILROY,J.J.POST,A.KELLEHER,H.M.JACK,C.C.GOODNOW, JRNL AUTH 5 S.G.TURVILLE,W.D.RAWLINSON,R.A.BULL,A.G.STEWART,P.M.HANSBRO, JRNL AUTH 6 D.CHRIST JRNL TITL BROADLY NEUTRALIZING SARS-COV-2 ANTIBODIES THROUGH JRNL TITL 2 EPITOPE-BASED SELECTION FROM CONVALESCENT PATIENTS. JRNL REF NAT COMMUN V. 14 687 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 36755042 JRNL DOI 10.1038/S41467-023-36295-5 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.09 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 34123 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 1688 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.0850 - 5.1493 0.99 2795 174 0.1951 0.2369 REMARK 3 2 5.1493 - 4.0879 1.00 2742 129 0.1594 0.1932 REMARK 3 3 4.0879 - 3.5713 1.00 2737 135 0.1959 0.2369 REMARK 3 4 3.5713 - 3.2449 1.00 2693 134 0.2216 0.2424 REMARK 3 5 3.2449 - 3.0123 1.00 2698 145 0.2476 0.2722 REMARK 3 6 3.0123 - 2.8348 1.00 2667 143 0.2491 0.3258 REMARK 3 7 2.8348 - 2.6928 1.00 2713 126 0.2443 0.2827 REMARK 3 8 2.6928 - 2.5756 1.00 2700 124 0.2560 0.3495 REMARK 3 9 2.5756 - 2.4764 1.00 2643 150 0.2623 0.3118 REMARK 3 10 2.4764 - 2.3910 1.00 2673 150 0.2739 0.3227 REMARK 3 11 2.3910 - 2.3162 1.00 2639 140 0.2770 0.3548 REMARK 3 12 2.3162 - 2.2500 1.00 2735 138 0.2979 0.3773 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.510 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 51.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 71.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4898 REMARK 3 ANGLE : 0.951 6689 REMARK 3 CHIRALITY : 0.057 750 REMARK 3 PLANARITY : 0.006 860 REMARK 3 DIHEDRAL : 5.844 3860 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -0.1506 -0.6405 -26.8762 REMARK 3 T TENSOR REMARK 3 T11: 0.4475 T22: 0.5273 REMARK 3 T33: 0.4099 T12: -0.0087 REMARK 3 T13: -0.0212 T23: -0.0584 REMARK 3 L TENSOR REMARK 3 L11: 2.2952 L22: 1.3316 REMARK 3 L33: 1.0071 L12: -1.2984 REMARK 3 L13: -0.5227 L23: 0.1370 REMARK 3 S TENSOR REMARK 3 S11: -0.1389 S12: -0.3230 S13: -0.0453 REMARK 3 S21: 0.1289 S22: 0.1122 S23: 0.1489 REMARK 3 S31: -0.0795 S32: -0.3988 S33: 0.0289 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8DXT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1000267534. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUN-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34125 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 48.085 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.92900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: PDB 5I1B (FAB) AND GENERIC SARS-COV-2 RBD REMARK 200 REMARK 200 REMARK: RODS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AN EQUAL VOLUME (2 UL) OF PROTEIN REMARK 280 SOLUTION AT ~5 MG/ML (IN 25 MM TRIS (PH 8.0), 200 MM NACL) WAS REMARK 280 COMBINED WITH WELL SOLUTION (100 MM AMMONIUM CITRATE (PH 5.5), REMARK 280 20% (W/V) PEG3350., VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z+1/2 REMARK 290 4555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 35.52487 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.97700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 90.81670 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 35.52487 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 20.97700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 90.81670 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, R, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU L 212 REMARK 465 CYS L 213 REMARK 465 SER L 214 REMARK 465 SER H 137 REMARK 465 SER H 138 REMARK 465 LYS H 139 REMARK 465 SER H 140 REMARK 465 THR H 141 REMARK 465 SER H 142 REMARK 465 GLY H 143 REMARK 465 GLY H 144 REMARK 465 LYS H 224 REMARK 465 SER H 225 REMARK 465 CYS H 226 REMARK 465 GLY H 227 REMARK 465 SER H 228 REMARK 465 HIS H 229 REMARK 465 HIS H 230 REMARK 465 HIS H 231 REMARK 465 HIS H 232 REMARK 465 HIS H 233 REMARK 465 HIS H 234 REMARK 465 THR R 333 REMARK 465 SER R 530 REMARK 465 HIS R 531 REMARK 465 HIS R 532 REMARK 465 HIS R 533 REMARK 465 HIS R 534 REMARK 465 HIS R 535 REMARK 465 HIS R 536 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP L 1 CG OD1 OD2 REMARK 470 GLN L 3 CG CD OE1 NE2 REMARK 470 ARG L 24 CG CD NE CZ NH1 NH2 REMARK 470 LYS L 125 CG CD CE NZ REMARK 470 VAL L 149 CG1 CG2 REMARK 470 ASP L 150 CG OD1 OD2 REMARK 470 LYS L 168 CG CD CE NZ REMARK 470 GLU L 186 CG CD OE1 OE2 REMARK 470 LYS L 187 CG CD CE NZ REMARK 470 LYS L 189 CG CD CE NZ REMARK 470 VAL L 190 CG1 CG2 REMARK 470 SER H 166 OG REMARK 470 LEU H 169 CG CD1 CD2 REMARK 470 SER H 197 OG REMARK 470 LYS H 211 CG CD CE NZ REMARK 470 LYS H 220 CG CD CE NZ REMARK 470 ASN R 334 CG OD1 ND2 REMARK 470 GLU R 340 CG CD OE1 OE2 REMARK 470 LYS R 386 CG CD CE NZ REMARK 470 ASN R 481 CG OD1 ND2 REMARK 470 VAL R 483 CG1 CG2 REMARK 470 LYS R 528 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA L 51 -38.08 71.07 REMARK 500 SER L 77 94.73 65.96 REMARK 500 LEU L 94 -160.21 55.28 REMARK 500 ALA L 152 -156.66 -98.20 REMARK 500 GLN L 154 114.56 64.41 REMARK 500 LYS L 168 -75.22 -62.13 REMARK 500 GLU H 89 -6.86 -58.07 REMARK 500 ASP H 154 62.72 68.36 REMARK 500 SER H 196 -153.74 -64.50 REMARK 500 SER H 197 -43.77 61.45 REMARK 500 PHE R 377 83.93 -161.67 REMARK 500 ASN R 422 -53.52 -131.56 REMARK 500 ASN R 481 29.63 46.73 REMARK 500 REMARK 500 REMARK: NULL DBREF 8DXT L 1 214 PDB 8DXT 8DXT 1 214 DBREF 8DXT H 1 234 PDB 8DXT 8DXT 1 234 DBREF 8DXT R 333 528 UNP P0DTC2 SPIKE_SARS2 333 528 SEQADV 8DXT GLY R 529 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXT SER R 530 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXT HIS R 531 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXT HIS R 532 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXT HIS R 533 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXT HIS R 534 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXT HIS R 535 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXT HIS R 536 UNP P0DTC2 EXPRESSION TAG SEQRES 1 L 214 ASP ILE GLN MET THR GLN SER PRO SER THR LEU SER ALA SEQRES 2 L 214 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 L 214 GLN SER ILE GLY ARG TRP LEU ALA TRP TYR GLN GLN LYS SEQRES 4 L 214 PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR ASP ALA SER SEQRES 5 L 214 SER LEU GLU SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 L 214 GLY PHE GLY THR GLU PHE THR LEU THR ILE SER SER LEU SEQRES 7 L 214 GLN PRO ASP ASP PHE ALA THR TYR TYR CYS GLN GLN CYS SEQRES 8 L 214 ASP SER LEU LEU THR PHE GLY GLY GLY THR LYS LEU GLU SEQRES 9 L 214 ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE PHE SEQRES 10 L 214 PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SER SEQRES 11 L 214 VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU ALA SEQRES 12 L 214 LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER GLY SEQRES 13 L 214 ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS ASP SEQRES 14 L 214 SER THR TYR SER LEU SER SER THR LEU THR LEU SER LYS SEQRES 15 L 214 ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU VAL SEQRES 16 L 214 THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER PHE SEQRES 17 L 214 ASN ARG GLY GLU CYS SER SEQRES 1 H 234 GLU VAL GLN LEU VAL GLN SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 234 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 H 234 PHE THR PHE SER SER TYR ALA MET SER TRP VAL ARG GLN SEQRES 4 H 234 ALA PRO GLY LYS GLY LEU GLU TRP VAL LEU SER ILE SER SEQRES 5 H 234 GLY SER GLY GLY SER THR TYR TYR ALA ASP SER VAL LYS SEQRES 6 H 234 GLY ARG PHE THR ILE SER ILE ASP ASN SER LYS LYS THR SEQRES 7 H 234 VAL TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 H 234 ALA VAL TYR TYR CYS ALA LYS SER GLY GLU GLN GLN LEU SEQRES 9 H 234 VAL GLN ALA GLU TYR PHE HIS HIS TRP GLY GLN GLY THR SEQRES 10 H 234 LEU VAL THR VAL SER SER ALA SER THR LYS GLY PRO SER SEQRES 11 H 234 VAL PHE PRO LEU ALA PRO SER SER LYS SER THR SER GLY SEQRES 12 H 234 GLY THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE SEQRES 13 H 234 PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU SEQRES 14 H 234 THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SEQRES 15 H 234 SER GLY LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SEQRES 16 H 234 SER SER SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL SEQRES 17 H 234 ASN HIS LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL SEQRES 18 H 234 GLU PRO LYS SER CYS GLY SER HIS HIS HIS HIS HIS HIS SEQRES 1 R 204 THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR SEQRES 2 R 204 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 3 R 204 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER SEQRES 4 R 204 ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO SEQRES 5 R 204 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 6 R 204 ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE SEQRES 7 R 204 ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR SEQRES 8 R 204 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 9 R 204 ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR SEQRES 10 R 204 ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 11 R 204 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 12 R 204 GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS SEQRES 13 R 204 TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR ASN SEQRES 14 R 204 GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 R 204 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO SEQRES 16 R 204 LYS GLY SER HIS HIS HIS HIS HIS HIS HET NAG A 1 14 HET NAG A 2 14 HET FUC A 3 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 4 NAG 2(C8 H15 N O6) FORMUL 4 FUC C6 H12 O5 FORMUL 5 HOH *90(H2 O) HELIX 1 AA1 GLN L 79 PHE L 83 5 5 HELIX 2 AA2 SER L 120 GLY L 127 1 8 HELIX 3 AA3 LYS L 182 LYS L 187 1 6 HELIX 4 AA4 THR H 28 TYR H 32 5 5 HELIX 5 AA5 ASN H 74 LYS H 76 5 3 HELIX 6 AA6 ARG H 87 THR H 91 5 5 HELIX 7 AA7 SER H 197 THR H 201 5 5 HELIX 8 AA8 LYS H 211 ASN H 214 5 4 HELIX 9 AA9 PRO R 337 ASN R 343 1 7 HELIX 10 AB1 SER R 349 TRP R 353 5 5 HELIX 11 AB2 ASP R 364 SER R 371 1 8 HELIX 12 AB3 SER R 383 ASN R 388 1 6 HELIX 13 AB4 ASP R 405 ILE R 410 5 6 HELIX 14 AB5 GLY R 416 ASN R 422 1 7 HELIX 15 AB6 SER R 438 SER R 443 1 6 HELIX 16 AB7 GLY R 502 TYR R 505 5 4 SHEET 1 AA1 4 MET L 4 SER L 7 0 SHEET 2 AA1 4 VAL L 19 ALA L 25 -1 O THR L 22 N SER L 7 SHEET 3 AA1 4 GLU L 70 ILE L 75 -1 O PHE L 71 N CYS L 23 SHEET 4 AA1 4 PHE L 62 GLY L 66 -1 N SER L 63 O THR L 74 SHEET 1 AA2 6 THR L 10 ALA L 13 0 SHEET 2 AA2 6 THR L 101 ILE L 105 1 O LYS L 102 N LEU L 11 SHEET 3 AA2 6 THR L 85 GLN L 90 -1 N TYR L 86 O THR L 101 SHEET 4 AA2 6 LEU L 33 GLN L 38 -1 N TYR L 36 O TYR L 87 SHEET 5 AA2 6 LYS L 45 TYR L 49 -1 O LEU L 47 N TRP L 35 SHEET 6 AA2 6 SER L 53 LEU L 54 -1 O SER L 53 N TYR L 49 SHEET 1 AA3 4 THR L 10 ALA L 13 0 SHEET 2 AA3 4 THR L 101 ILE L 105 1 O LYS L 102 N LEU L 11 SHEET 3 AA3 4 THR L 85 GLN L 90 -1 N TYR L 86 O THR L 101 SHEET 4 AA3 4 THR L 96 PHE L 97 -1 O THR L 96 N GLN L 90 SHEET 1 AA4 4 SER L 113 PHE L 117 0 SHEET 2 AA4 4 THR L 128 PHE L 138 -1 O LEU L 134 N PHE L 115 SHEET 3 AA4 4 TYR L 172 SER L 181 -1 O LEU L 178 N VAL L 131 SHEET 4 AA4 4 SER L 158 VAL L 162 -1 N GLN L 159 O THR L 177 SHEET 1 AA5 3 LYS L 144 VAL L 149 0 SHEET 2 AA5 3 VAL L 190 THR L 196 -1 O GLU L 194 N GLN L 146 SHEET 3 AA5 3 VAL L 204 ASN L 209 -1 O LYS L 206 N CYS L 193 SHEET 1 AA6 4 GLN H 3 SER H 7 0 SHEET 2 AA6 4 LEU H 18 SER H 25 -1 O ALA H 23 N VAL H 5 SHEET 3 AA6 4 THR H 78 MET H 83 -1 O MET H 83 N LEU H 18 SHEET 4 AA6 4 PHE H 68 ASP H 73 -1 N THR H 69 O GLN H 82 SHEET 1 AA7 6 GLY H 10 VAL H 12 0 SHEET 2 AA7 6 THR H 117 VAL H 121 1 O THR H 120 N VAL H 12 SHEET 3 AA7 6 ALA H 92 LYS H 98 -1 N ALA H 92 O VAL H 119 SHEET 4 AA7 6 MET H 34 GLN H 39 -1 N VAL H 37 O TYR H 95 SHEET 5 AA7 6 LEU H 45 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 AA7 6 THR H 58 TYR H 60 -1 O TYR H 59 N SER H 50 SHEET 1 AA8 4 GLY H 10 VAL H 12 0 SHEET 2 AA8 4 THR H 117 VAL H 121 1 O THR H 120 N VAL H 12 SHEET 3 AA8 4 ALA H 92 LYS H 98 -1 N ALA H 92 O VAL H 119 SHEET 4 AA8 4 HIS H 112 TRP H 113 -1 O HIS H 112 N LYS H 98 SHEET 1 AA9 4 SER H 130 LEU H 134 0 SHEET 2 AA9 4 ALA H 146 TYR H 155 -1 O LYS H 153 N SER H 130 SHEET 3 AA9 4 TYR H 186 VAL H 194 -1 O TYR H 186 N TYR H 155 SHEET 4 AA9 4 VAL H 173 THR H 175 -1 N HIS H 174 O VAL H 191 SHEET 1 AB1 4 SER H 130 LEU H 134 0 SHEET 2 AB1 4 ALA H 146 TYR H 155 -1 O LYS H 153 N SER H 130 SHEET 3 AB1 4 TYR H 186 VAL H 194 -1 O TYR H 186 N TYR H 155 SHEET 4 AB1 4 VAL H 179 LEU H 180 -1 N VAL H 179 O SER H 187 SHEET 1 AB2 3 THR H 161 TRP H 164 0 SHEET 2 AB2 3 TYR H 204 HIS H 210 -1 O ASN H 207 N SER H 163 SHEET 3 AB2 3 THR H 215 VAL H 221 -1 O VAL H 217 N VAL H 208 SHEET 1 AB3 5 ASN R 354 ILE R 358 0 SHEET 2 AB3 5 ASN R 394 ARG R 403 -1 O VAL R 395 N ILE R 358 SHEET 3 AB3 5 PRO R 507 GLU R 516 -1 O TYR R 508 N ILE R 402 SHEET 4 AB3 5 GLY R 431 ASN R 437 -1 N ILE R 434 O VAL R 511 SHEET 5 AB3 5 THR R 376 TYR R 380 -1 N LYS R 378 O VAL R 433 SHEET 1 AB4 3 CYS R 361 VAL R 362 0 SHEET 2 AB4 3 VAL R 524 CYS R 525 1 O CYS R 525 N CYS R 361 SHEET 3 AB4 3 CYS R 391 PHE R 392 -1 N PHE R 392 O VAL R 524 SHEET 1 AB5 2 LEU R 452 ARG R 454 0 SHEET 2 AB5 2 LEU R 492 SER R 494 -1 O GLN R 493 N TYR R 453 SHEET 1 AB6 2 TYR R 473 GLN R 474 0 SHEET 2 AB6 2 CYS R 488 TYR R 489 -1 O TYR R 489 N TYR R 473 SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.06 SSBOND 2 CYS L 133 CYS L 193 1555 1555 2.04 SSBOND 3 CYS H 22 CYS H 96 1555 1555 2.04 SSBOND 4 CYS H 150 CYS H 206 1555 1555 2.05 SSBOND 5 CYS R 336 CYS R 361 1555 1555 2.07 SSBOND 6 CYS R 379 CYS R 432 1555 1555 2.10 SSBOND 7 CYS R 391 CYS R 525 1555 1555 2.04 SSBOND 8 CYS R 480 CYS R 488 1555 1555 2.05 LINK ND2 ASN R 343 C1 NAG A 1 1555 1555 1.44 LINK O4 NAG A 1 C1 NAG A 2 1555 1555 1.44 LINK O6 NAG A 1 C1 FUC A 3 1555 1555 1.44 CISPEP 1 SER L 7 PRO L 8 0 -2.56 CISPEP 2 TYR L 139 PRO L 140 0 4.73 CISPEP 3 PHE H 156 PRO H 157 0 -6.49 CISPEP 4 GLU H 158 PRO H 159 0 2.71 CRYST1 93.609 41.954 183.029 90.00 97.08 90.00 I 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010683 0.000000 0.001326 0.00000 SCALE2 0.000000 0.023836 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005506 0.00000